MADRIGAL PHARMACEUTICALS, INC. — Revenue by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e4521d3a-8948-4e87-8d75-e20422a04f78/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $958.4M | 2025-01-01 – 2025-12-31 | evidence 0001628280-26-009514 |
| FY 2024 | $180.1M | 2024-01-01 – 2024-12-31 | evidence 0001628280-25-007980 |
| FY 2023 | $0 | 2023-01-01 – 2023-12-31 | evidence 0001628280-25-007980 |
| FY 2022 | $0 | 2022-01-01 – 2022-12-31 | evidence 0001628280-25-007980 |
| FY 2021 | $0 | 2021-01-01 – 2021-12-31 | evidence 0001628280-24-007376 |
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001193125-21-056164 |
| FY 2019 | $0 | 2019-01-01 – 2019-12-31 | evidence 0001193125-20-049021 |
| FY 2018 | $0 | 2018-01-01 – 2018-12-31 | evidence 0001193125-20-049021 |
| FY 2017 | $0 | 2017-01-01 – 2017-12-31 | evidence 0001193125-20-049021 |
| FY 2012 | $147.0k | 2012-01-01 – 2012-12-31 | evidence 0001047469-15-002022 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MADRIGAL PHARMACEUTICALS, INC. — all facts · Net Income · Operating Income